Ledger.Open graph →
SEC Form D · filed June 2, 2021

Cellebration Life Sciences, Inc

Offering
$20.0M
Sold
$285K
Exemption
Rule 506(c)
Industry
Biotechnology
Location
PHOENIX, AZ
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (12)

Anand Srivastava · San Diego, CADirectorDeven Patel · San Diego, CADirectorBill Deegan · Phoenix, AZDirectorTim Kopatich · Phoenix, AZExecDana Stalder · San Francisco, CAExecMatthew Killebrew · Dallas, TXDirectorAnna-Lena Kamenetzky · San Francisco, CADirectorZubin Bhettay · San Francisco, CADirectorHallbjorn Karlsson · New York, NYExecGregg Rubin · New York, NYDirectorGrace Ray · New York, NYDirectorAnthony Sciortino · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗